Nigerian Healthtech Startup, Remedial Health Secures $4.4 Million in Seed Funding
Remedial Health, a health-tech firm that develops solutions to enhance the efficiency of Africa’s pharmaceutical value chain, has acquired $4.4 million in seed funding.
Leading the seed round of funding was Global Ventures.
Notable angel investors Guillaume Luccisano and Christopher Golda joined Tencent, Y Combinator, Cathexis Ventures, LightSpeed Venture Partners Scout Fund, Ventures Platform, Alumni Ventures, and True Capital Management in the round.
Remedial Health provides a range of options, including its digital procurement and PMR (patient medication records) platforms, to help neighborhood pharmacies, PPMVs, and hospitals get affordable and trustworthy retail pharmaceuticals. Healthcare practitioners can purchase verified pharmaceuticals at costs that are comparable to or better than open-air medicine market prices with 24-hour delivery to their practice through Remedial Health’s logistics network.
According to Samuel Okwuada, CEO and co-founder of Remedial Health, “the funds that we have raised and the strategic support from our investors will enable us to deliver the solutions to address various challenges that have hampered these businesses’ growth for many years, and make it easier to safeguard lives and livelihoods across the continent for years to come.”
By leveraging the Remedial Health platform, neighborhood pharmacies, PPMVs, and hospitals can boost earnings through group/bulk purchasing discounts, time savings and streamlined operations, access to finance, and the provision of financial and other fundamental healthcare services.
This most recent round of finance would enable the business to accelerate its growth across Nigeria.
